| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |